Eilish Moore
Overview
Explore the profile of Eilish Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasan N, Nourse C, Schaaf H, Bekker A, Loveday M, Alcantara Gabardo B, et al.
Lancet Child Adolesc Health
. 2024 Mar;
8(5):369-378.
PMID: 38522446
Infants born to mothers with tuberculosis disease are at increased risk of developing tuberculosis disease themselves. We reviewed published studies and guidelines on the management of these infants to inform...
2.
Ng S, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, et al.
Nat Immunol
. 2024 Feb;
25(4):716.
PMID: 38360937
No abstract available.
3.
Moore E, Hughes M
Nurs Child Young People
. 2023 Feb;
35(5):14-21.
PMID: 36752164
Background: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in children. Premature infants and infants with underlying health issues are at increased risk of...
4.
Ng S, De Labastida Rivera F, Yan J, Corvino D, Das I, Zhang P, et al.
Nat Immunol
. 2020 Aug;
21(10):1205-1218.
PMID: 32839608
Immune-modulating therapies have revolutionized the treatment of chronic diseases, particularly cancer. However, their success is restricted and there is a need to identify new therapeutic targets. Here, we show that...
5.
Whelan B, Musters E, Murray A, Moore E, Lievaart L, Visser S, et al.
Drugs Ther Perspect
. 2016 Mar;
32:119-130.
PMID: 26924927
Severe infection of infants with respiratory syncytial virus (RSV) is a leading cause of morbidity in the developed world and mortality in the developing world. Prophylaxis using palivizumab in infants...